Faculty profile

Nelson Lee

Back to faculty

ProfessorEpidemiology DivisionUniversity of Toronto

Nelson Lee

Professor

Epidemiology Division

Dalla Lana School of Public Health

University of Toronto

Toronto, Ontario, Canada

Scholar ORCID

Supervision signals

Professors usually supervise graduate students in their department's programs.
9 publications in the last five years, latest in 2026.
Senior (last) author on 3 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

173

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Education

Doctor of Medicine (MD), research, Emerging Infectious Diseases
Fellow of Infectious Diseases Society of America (FIDSA)
FRCP (Lond)
Clinical fellowship in HIV/AIDS clinical and research program
MRCP(UK)
MBBS
FRCP (Edin)

Profiles and links

University Profile Google Scholar iDORCID

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Health Equity Health Systems Hospital Capacity Large-Scale Patient Transfers Patient Outcomes Processes Of Care Quality Of Inpatient Care

Latest papers

Factors associated with severe health outcomes among community-dwelling older adults hospitalized with respiratory syncytial virus
Journal of Infection · 2026
Limited durability of protection conferred by XBB.1.5 vaccines against omicron-associated severe outcomes among community-dwelling adults, Ontario, Canada.
Vaccine · 2025 · first author
Avian Influenza: Lessons from Past Outbreaks and an Inventory of Data Sources, Mathematical and AI Models, and Early Warning Systems for Forecasting and Hotspot Detection to Tackle Ongoing Outbreaks.
Healthcare (Basel, Switzerland) · 2024

All 9 publications

Latest funding

More than a Cold: Defining and Quantifying the Population Attributable Fraction for Infectious and Non-infectious Diseases for Common Respiratory Viral Infections
CIHR · 2024 · Co-investigator
$306,000
Engaging communities at high risk of H5N1: a survey to inform surveillance and outbreak response
CIHR · 2024 · Co-investigator
$149,740
Evaluating the effectiveness and implementation process of population-level interventions to reduce inappropriate use of antibiotics in primary care settings to inform policy development in Canada
CIHR · 2023 · Co-investigator
$299,980

All 13 grants and awards

9 publications.

Factors associated with severe health outcomes among community-dwelling older adults hospitalized with respiratory syncytial virus

Atukorale VN, Kwong JC, Hernandez A, Moineddin R, Lee N, Kopp A, Andrew MK, Bronskill SE, Brown KA, Daneman N

Journal of Infection2026

DOI: 10.1016/j.jinf.2026.106797

Limited durability of protection conferred by XBB.1.5 vaccines against omicron-associated severe outcomes among community-dwelling adults, Ontario, Canada.

Lee N, Nguyen L, Nasreen S, Austin PC, Brown KA, Buchan SA, Grewal R, Schwartz KL, Tadrous M, Wilson K, Wilson SE, Kwong JC, Canadian Immunization Research Network (CIRN) Investigators

Vaccine2025First author

DOI: 10.1016/j.vaccine.2025.127300 PMID: 40424706

Avian Influenza: Lessons from Past Outbreaks and an Inventory of Data Sources, Mathematical and AI Models, and Early Warning Systems for Forecasting and Hotspot Detection to Tackle Ongoing Outbreaks.

Musa E, Nia ZM, Bragazzi NL, Leung D, Lee N, Kong JD

Healthcare (Basel, Switzerland)2024

DOI: 10.3390/healthcare12191959 PMID: 39408139

Protection Conferred by COVID-19 Vaccination, Prior SARS-CoV-2 Infection, or Hybrid Immunity Against Omicron-Associated Severe Outcomes Among Community-Dwelling Adults.

Lee N, Nguyen L, Austin PC, Brown KA, Grewal R, Buchan SA, Nasreen S, Gubbay J, Schwartz KL, Tadrous M, Wilson K, Wilson SE, Kwong JC

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America2024First author

DOI: 10.1093/cid/ciad716 PMID: 38001037

Oseltamivir May or May Not Reduce Hospitalizations.

Uyeki TM, Hui DSC, Lee N

JAMA internal medicine2024Senior author

DOI: 10.1001/jamainternmed.2023.4711 PMID: 37983025

RSV-associated hospitalization in adults in the USA: A retrospective chart review investigating burden, management strategies, and outcomes.

Walsh E, Lee N, Sander I, Stolper R, Zakar J, Wyffels V, Myers D, Fleischhackl R

Health science reports2022

DOI: 10.1002/hsr2.556 PMID: 35509398

Influenza: clinical aspects, diagnosis, and treatment.

Sukhdeo S, Lee N

Current opinion in pulmonary medicine2022Senior author

DOI: 10.1097/mcp.0000000000000860 PMID: 35125406

Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial.

Kumar D, Ison MG, Mira JP, Welte T, Hwan Ha J, Hui DS, Zhong N, Saito T, Katugampola L, Collinson N, Williams S, Wildum S, Ackrill A, Clinch B, Lee N

The Lancet. Infectious diseases2022Senior author

DOI: 10.1016/s1473-3099(21)00469-2 PMID: 35085510

Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial

Ali K, Azher T, Baqi M, Binnie A, Borgia S, Carrier FM, Cavayas YA, Chagnon N, Cheng MP, Conly J

CANADIAN MEDICAL ASSOCIATION JOURNAL2022173 citations

DOI: 10.1503/cmaj.211698

Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Nelson Lee

Research

Latest papers

Latest funding

Factors associated with severe health outcomes among community-dwelling older adults hospitalized with respiratory syncytial virus

Limited durability of protection conferred by XBB.1.5 vaccines against omicron-associated severe outcomes among community-dwelling adults, Ontario, Canada.

Avian Influenza: Lessons from Past Outbreaks and an Inventory of Data Sources, Mathematical and AI Models, and Early Warning Systems for Forecasting and Hotspot Detection to Tackle Ongoing Outbreaks.

Protection Conferred by COVID-19 Vaccination, Prior SARS-CoV-2 Infection, or Hybrid Immunity Against Omicron-Associated Severe Outcomes Among Community-Dwelling Adults.

Oseltamivir May or May Not Reduce Hospitalizations.

RSV-associated hospitalization in adults in the USA: A retrospective chart review investigating burden, management strategies, and outcomes.

Influenza: clinical aspects, diagnosis, and treatment.

Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial.

Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial

Frequent collaborators

Ramandip Grewal

Mina Tadrous

Nick Daneman

Kumanan Wilson

Yoav Keynan

Srinivas Murthy

Jennie Johnstone

Francois Lamontagne

Michael Fralick

Madeleine Durand

Ameeta Singh

Srinivas Murthy

Michael Silverman

Peter Daley

Madeleine Durand

Yoav Keynan

Ameeta Singh

Michael Fralick

Shelly Bolotin

Nick Daneman

Jennifer Grant

Ranjani Somayaji

Jennifer Tsang

Erick Duan

Sergio Borgia

Karim Ali

Ryan Zarychanski

Alexis Turgeon

Marina Klein

Francois Lamontagne

Marina Klein

Samira Mubareka

Shane English

Alexis Turgeon

Patricia Fontela

Cecilia Costiniuk

Srinivas Murthy

John Conly

Makeda Semret

Madeleine Durand